Product image of Yorvipath (Palopegteriparatide) supplied by GNH India

Yorvipath

Active Ingredient:
Palopegteriparatide
Origin:
EU

Yorvipath (Palopegteriparatide)

Yorvipath (palopegteriparatide) is a parathyroid hormone analog prescribed for adults with hypoparathyroidism. This injectable therapy supports calcium balance and bone health. Designed for subcutaneous use, it offers a once-daily option for long-term management. Ideal for patients seeking stable symptom control.

Manufacturer / TM Owner

Ascendis Pharma Bone Diseases A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Palopegteriparatide is used to treat hypoparathyroidism in adults, a condition where the body produces too little parathyroid hormone. This hormone helps regulate calcium and phosphate levels in the blood and bones. By mimicking its action, the medication helps maintain proper mineral balance. It is typically prescribed when standard treatments are insufficient.

Side Effects

  • Users may notice improved calcium levels and reduced symptoms like muscle cramps or tingling. Some experience better energy levels and fewer bone-related discomforts over time. The medication works gradually, so noticeable changes often appear within weeks. Individual responses vary based on condition and lifestyle.

Precautions & Warnings

  • Store Yorvipath in the refrigerator until use to maintain potency. Keep the pen away from direct light and avoid freezing. Always check the solution for particles or discoloration before injecting. Dispose of used needles properly to prevent contamination or injury. Consult a healthcare provider if you experience persistent discomfort at the injection site.

Avoid Interactions

  • Alcohol may reduce the effectiveness of palopegteriparatide, so moderation is advised. Certain medications, like diuretics or steroids, can affect calcium levels and should be discussed with a doctor. Always inform your healthcare provider about all prescriptions, over-the-counter drugs, and supplements you are taking. Some interactions may require dose adjustments or monitoring.

Frequently Asked Questions

Yorvipath is prescribed to treat hypoparathyroidism in adults by helping regulate calcium and phosphate levels.

It is given as a subcutaneous injection, typically once daily, using a pre-filled pen.

Yorvipath is available by prescription; consult a licensed pharmacy for availability and ordering options.

Common effects may include injection site reactions, nausea, or headache. Report persistent issues to a healthcare provider.

Safety during pregnancy has not been established; discuss risks and benefits with a healthcare professional.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Palopegteriparatide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT